Corona beer owner Constellation Brands is set to pour some $4bn (£3.15bn) into Canada's top cannabis producer, Canopy Growth, in a deal marking the largest investment in the industry to date. Last year, Constellation injected $200m into Canopy in a deal to produce a non-alcoholic cannabis-based beverage. The alcohol firm wants to capitalise on the growing legalisation of the drug. On news of the deal, Canopy's Toronto-listed stock surged 30%, while on Wall Street, Constellation's fell 6%. The two firms said the investment would allow Canopy to expand its business reach "in the nearly 30 countries pursuing a federally permissible medical cannabis programme". Canopy, which has the largest legal cannabis production footprint in the world, currently produces cannabis-based oils and soft gel caps, among other products. With Constellation's latest injection of cash, Canopy plans to expand its suite of products to include edible bars, inhalers and pre-r...
Comments
Post a Comment